Expanded Noninvasive Genomic Medical Assessment: The Enigma Study

CompletedOBSERVATIONAL
Enrollment

760

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Down SyndromeEdwards SyndromePatau SyndromeKlinefelter SyndromeTurner SyndromeDiGeorge SyndromeChromosome DeletionAneuploidy
Interventions
OTHER

Blood sampling for Laboratory Developed Test (LDT) analysis

Each enrolled subject, either in the first or second trimester, will donate up to 50 mL (just over 3 tablespoons) of whole blood for development of the LDT

Trial Locations (8)

11220

Newlife Wellness OBGYN, Brooklyn

28117

Lakeshore Women's Specialists, Mooresville

37403

Regional Obstetrical Consultants, Chattanooga

44857

James D. Kasten, M.D., Inc., Norwalk

45219

Cincinnati Obgyn, Cincinnati

70535

Heinen Obstectrics & Gynecology, Eunice

77598

Texas Maternal-Fetal Medicine, Webster

85258

Valley Perinatal, Scottsdale

All Listed Sponsors
lead

Progenity, Inc.

INDUSTRY

NCT02787486 - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study | Biotech Hunter | Biotech Hunter